Skip to main content
SpringerLink
Log in

Belatacept for KTx: better QOL, fewer side effects

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2-point difference in PCS, 3-point difference in MCS

Reference

  • Dobbels F, et al. Beneficial Effect of Belatacept on Health-Related Quality of Life and Perceived Side Effects: Results From the BENEFIT and BENEFIT-EXT Trials. Transplantation : 14 May 2014. Available from: URL: http://doi.org/10.1097/TP.0000000000000159

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Belatacept for KTx: better QOL, fewer side effects. PharmacoEcon Outcomes News 704, 8 (2014). https://doi.org/10.1007/s40274-014-1292-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1292-2

Search

Navigation